Sign in to confirm you’re not a bot

This helps protect our community. Learn more

Sign in

179th Meeting of Vaccines and Related Biological Products Advisory Committee - Day 1

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Verified

179K subscribers

Subscribe

Subscribed

Like

Share

Save

From a US national health authority

Learn how experts define health sources in a journal of the National Academy of Medicine

8.4K views Streamed 2 years ago

8,433 views • Streamed live on Feb 28, 2023

RSV Vaccine ...more

...more

Comments are turned off. Learn more

Description

179th Meeting of Vaccines and Related Biological Products Advisory Committee - Day 1

RSV Vaccine

Transcript

Follow along using the transcript.

Show transcript

U.S. Food and Drug Administration

179K subscribers

Videos

About

Transcript

Live chat replay was turned off for this video.

7:00:43

185th Meeting of Vaccines and Related Biological Products Advisory Committee

U.S. Food and Drug Administration

12K views • Streamed 1 year ago

4:40:30

July 9, 2025: Pediatric Advisory Committee

U.S. Food and Drug Administration

1.1K views • Streamed 15 hours ago

New

5:46:31

179th Meeting of Vaccines and Related Biological Products Advisory Committee

U.S. Food and Drug Administration

6.7K views • Streamed 2 years ago

4:34:39

FDA & NIH Workshop on Reducing Animal Testing

U.S. Food and Drug Administration

13K views • Streamed 2 days ago

New

18:21

GDF2025-D2S08-Common Clinical Deficiencies in ANDAs Containing Comparative Clinical Endpoint Studies

U.S. Food and Drug Administration

361 views • 2 weeks ago

15:39

mRNA COVID Shots Cause Myocarditis

U.S. Food and Drug Administration

22K views • 8 days ago

20:05

GDF2025 – D2S13 - Navigating Challenges in Drug Manufacturing

U.S. Food and Drug Administration

237 views • 2 weeks ago

8:50:55

Vaccines and Related Biological Products Advisory Committee - 10/22/2020

U.S. Food and Drug Administration

363K views • Streamed 4 years ago

26:27

GDF2025 - D2S09 - Questions & Panel Discussion - Session Two

U.S. Food and Drug Administration

252 views • 2 weeks ago

15:34

GDF2025 – D2S17 - Case Studies of Using Alternate Reference Standard in Bioequivalence Studies

U.S. Food and Drug Administration

418 views • 2 weeks ago

8:11:11

Vaccines and Related Biological Products Advisory Committee – 6/14/2022

U.S. Food and Drug Administration

22K views • Streamed 3 years ago

18:50

GDF2025-D2S11- Common Deficiencies in Drug Master Files (DMFs)

U.S. Food and Drug Administration

434 views • 2 weeks ago

8:09:40

Vaccines and Related Biological Products Advisory Committee – 9/17/2021

U.S. Food and Drug Administration

1.6M views • Streamed 3 years ago

22:15

GDF2025-D2S10- GDUFA III Impact on Drug Master File (DMF) Assessment

U.S. Food and Drug Administration

129 views • 2 weeks ago

14:47

GDF2025-D2S18- Common Bioequivalence Information Requests: Tips for Facilitating the Review Process

U.S. Food and Drug Administration

228 views • 2 weeks ago

17:30

GDF2025 - D2S04 - Questions & Panel Discussion - Session One

U.S. Food and Drug Administration

178 views • 2 weeks ago

17:11

GDF2025 - D2S12- Common Quality Major Deficiencies in Abbreviated New Drug Applications (ANDAs)

U.S. Food and Drug Administration

390 views • 2 weeks ago

20:39

GDF2025 – D2S16 - Orange Book Drug Marketing Status

U.S. Food and Drug Administration

192 views • 2 weeks ago

18:31

GDF2025 - D2S15 - Questions & Panel Discussion - Session Three

U.S. Food and Drug Administration

181 views • 2 weeks ago

14:38

GDF2025 - D2S03- Bioequivalence Approaches for Nitrosamine Impacted ANDA Applications: Case Studies

U.S. Food and Drug Administration

138 views • 2 weeks ago